CD20 protein
E261827
CD20 protein is a cell-surface antigen found primarily on B lymphocytes and is a key therapeutic target in certain autoimmune diseases and B-cell malignancies.
All labels observed (5)
| Label | Occurrences |
|---|---|
| CD20 antigen | 3 |
| B‑lymphocyte antigen CD20 | 1 |
| CD20 | 1 |
| CD20 protein canonical | 1 |
| LEU‑16 antigen | 1 |
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
B‑cell marker
ⓘ
cell surface antigen ⓘ drug target ⓘ membrane protein ⓘ |
| alternativeName |
B1 antigen
ⓘ
Bp35 ⓘ CD20 protein ⓘ
surface form:
B‑lymphocyte antigen CD20
CD20 protein ⓘ
surface form:
LEU‑16 antigen
|
| belongsToFamily | membrane‑spanning 4‑domains subfamily A (MS4A) ⓘ |
| biologicalProcess |
B‑cell activation
ⓘ
B‑cell differentiation ⓘ B‑cell proliferation ⓘ regulation of calcium ion transport ⓘ |
| cellularLocation | plasma membrane ⓘ |
| encodedBy | MS4A1 gene ⓘ |
| expressedIn |
human immune system
ⓘ
lymph nodes ⓘ peripheral blood B cells ⓘ spleen B cells ⓘ |
| foundIn |
B lymphocyte membrane
ⓘ
mature B cells ⓘ pre‑B cells ⓘ |
| hasTransmembraneDomains | 4 ⓘ |
| molecularFunction |
B‑cell receptor signaling modulator
ⓘ
calcium ion channel regulator activity ⓘ |
| notExpressedIn |
hematopoietic stem cells
ⓘ
normal plasma cells ⓘ pro‑B cells ⓘ |
| organism | Homo sapiens ⓘ |
| postTranslationalModification | glycosylation ⓘ |
| recognizedBy | anti‑CD20 monoclonal antibodies ⓘ |
| targetOf |
mosunetuzumab (bispecific antibody component)
ⓘ
Rituxan ⓘ
surface form:
obinutuzumab
ocrelizumab ⓘ Ofatumumab ⓘ
surface form:
ofatumumab
Ofatumumab ⓘ
surface form:
ofatumumab (autoimmune indications)
Rituxan ⓘ
surface form:
rituximab
|
| therapeuticArea |
B‑cell non‑Hodgkin lymphoma
ⓘ
chronic lymphocytic leukemia ⓘ granulomatosis with polyangiitis ⓘ microscopic polyangiitis ⓘ multiple sclerosis ⓘ pemphigus vulgaris ⓘ rheumatoid arthritis ⓘ |
| topology | multi‑pass transmembrane protein ⓘ |
| usedAs |
diagnostic marker for B‑cell leukemias
ⓘ
diagnostic marker for B‑cell lymphomas ⓘ |
| usedIn |
immunohistochemistry of lymphoid tissues
ⓘ
immunophenotyping of B cells by flow cytometry ⓘ |
Referenced by (7)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
B‑lymphocyte antigen CD20
this entity surface form:
LEU‑16 antigen
this entity surface form:
CD20